PTSD

Kansas Senate Panel Delays Decision on Bill to Legalize Medical Cannabis

Source Node: https://zephyrnet.com/kansas-senate-panel-tables-medical-cannabis-legalization-bill/
Time Stamp: March 21, 2023 8:00 AM - Modified On: March 21, 2023 - Published By:
Source Cluster:
Published by Plato

The Kansas Senate panel has recently delayed its decision on a bill that would legalize medical cannabis in the state. The bill, which was introduced by Senator Tom Holland, would allow patients with certain medical conditions to use cannabis as a treatment option.The decision to delay the bill comes after several hearings were held to discuss the potential benefits and drawbacks of legalizing medical cannabis. Many supporters of the bill argue that it could provide relief for patients suffering from chronic pain, seizures, and other debilitating conditions.However, opponents of the

Weedmaps Answers 20 Frequently Asked Questions About Cannabis Use in Missouri

Source Node: https://zephyrnet.com/missouri-asked-weedmaps-answered-20-weed-faqs-for-missouri-stoners/
Time Stamp: March 10, 2023 1:57 AM - Modified On: March 10, 2023 - Published By:
Source Cluster:
Published by Plato

Cannabis use is becoming increasingly popular in Missouri, and with that comes a lot of questions. To help clarify the legal landscape and answer some of the most common questions about cannabis use in the state, Weedmaps has compiled this list of frequently asked questions.1. Is cannabis legal in Missouri?Yes, cannabis is legal for medical use in Missouri. The state passed a law in 2018 that allows for the cultivation, sale, and use of medical marijuana. Patients must obtain a medical marijuana card from the Missouri Department of Health and

MediPharm Labs Announces Clinical Trial Progress, Including FDA Approval of Partner Study

Source Node: https://zephyrnet.com/medipharm-labs-provides-update-on-clinical-trial-progress-including-fda-approval-of-partner-study/
Time Stamp: March 3, 2023 3:04 PM - Modified On: March 3, 2023 - Published By:
Source Cluster:
Published by Plato

MediPharm Labs, a leading cannabis extraction and product development company, recently announced progress on their clinical trials, including the FDA approval of a partner study. The news marks a major milestone for the company, as it demonstrates their commitment to providing safe and effective cannabis products to consumers.The clinical trial in question is being conducted by MediPharm Labs’ partner, the University of Mississippi Medical Center. The study is focused on the effects of cannabis on chronic pain, and is the first of its kind to be approved by the FDA.